Evaluation of Effectiveness of the Web-Based Monitoring Program Given to Mothers of Premature Babies

November 16, 2023 updated by: Rukiye Çelik, Gazi University
The study was planned to determine the effect of the web-based hospital and home follow-up program given to mothers of premature infants on infant growth-development, repeated hospitalization of the infant, maternal stress, preparation for discharge, home care and problem-solving care skills.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The population of the study will consist of mothers of premature infants receiving care and treatment in the neonatal intensive care units where the study is planned to be conducted between November 15, 2023 and June 01, 2024. Since there is no similar study in the literature, the sample size of the study will be determined as a result of the post-hoc power analysis performed after the pre-application in all groups. Premature infants and their mothers sampled in the study will be assigned to the intervention and control groups by randomization with the stratified block method according to the gestation week, gender and birth weight of the infants. Block randomization will be done by creating 6 blocks consisting of 4 letters. Block randomization will be done by an academic independent of the research. The group with which the study will start will be determined by lottery by the independent academic and the participants will be assigned to the intervention and control groups with randomization envelopes. Mother Descriptive Information Form, Infant Descriptive Information and Follow-up Form, Preparation for Discharge from the Neonatal Intensive Care Unit and Home Care Scale, Neonatal Intensive Care Unit Parental Stress Scale, Problem Solving Skills Assessment Form, Ankara Developmental Screening Inventory, and Process Evaluation Form will be used for data collection. The research will be carried out in three stages; (1) creating the content of the follow-up program, (2) designing the web page, (3) implementing the program with mothers. The implementation of the program based on the Empowerment Model will be implemented in 3 stages: preparation of the premature infant hospitalized in the neonatal intensive care unit for discharge from the hospital, transition to home and home care.

Study Type

Interventional

Enrollment (Estimated)

62

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • For mothers

    • Those over 18 years of age,
    • Literate,
    • Having a computer or smartphone,
    • Having access to internet connection,
    • Able to use the Internet,
    • Able to speak Turkish,
    • Primiparous,
    • Mothers who agree to participate in the study will be included in the study.
  • For babies

    • 28-316. born during the week of pregnancy,
    • Birth weight 1000-2000 grams. the one which,
    • Hospitalized for at least 5 days,
    • Prematurity and related health problems (respiratory distress syndrome, intra cranial hemorrhage, patent ductus arteriosus, intrauterine growth retardation, small for gestational age, SEPSIS, retinopathy of prematurity, cholestasis, nutritional intolerance)
    • Babies without congenital anomalies will be included in the study.

Exclusion Criteria:

  • Mothers with physical and/or mental disabilities,
  • Mothers diagnosed with a psychological disease (severe depression, suicide attempt, etc.),
  • Mothers who are addicted to alcohol and substances,
  • Mothers who cannot complete the modules will not be included in the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
The presented modules will be made accessible to mothers in the experimental group through a website. The modules will be completed in order and the necessary forms and follow-ups will be completed at the end of each module.
The research will be carried out in three stages; (1) creating the content of the follow-up program, (2) designing the web page, (3) implementing the program with mothers. The topics to be included in the monitoring program will be prepared within the framework of the "Empowerment Model". Knowledge and attitude-self-efficacy will be tried to be increased with the modules to be prepared. Accordingly, the program is planned to consist of 3 modules. These are "Preparation for Hospital Discharge Module", "Transitional Care Module" and "Home Care Module". The presented modules will be made accessible to mothers in the experimental group through a website. The modules will be completed in order and the necessary forms and follow-ups will be completed at the end of each module.
No Intervention: Control Group
No intervention will be made in the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baby Monitoring Form
Time Frame: at birth, 1st month, 3rd month
Growth-development parameters of birth, discharge and home care (Height - meters)
at birth, 1st month, 3rd month
Neonatal Intensive Care Unit Parental Stress Scale
Time Frame: at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
Scale; The sub-dimensions are Babies' Appearance and Behavior, Sights and Sounds, Your Relationship with Your Baby, and Your Role as a Parent.
at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
Neonatal Intensive Care Unit Parental Stress Scale
Time Frame: at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
Scale; The sub-dimensions are Babies' Appearance and Behavior, Sights and Sounds, Your Relationship with Your Baby, and Your Role as a Parent.Items with a mean score between 3.0 and 3.40 are considered moderately stressful, and items with a mean score >3.40 are considered very stressful. The lowest score is 1, the highest score is 5.
at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
Problem Solving Skills Evaluation Form
Time Frame: at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
Subscales of the form are Child (Baby) Care Skill Subscale, Scanning Subscale, Formulation Subscale, Pre-evaluation (Prediction) Subscale, Planning Subscale, Application Subscale, Evaluation Subscale, Problem Solving Process Subscale.The lowest score that can be obtained from the entire scale is 27 and the highest score is 261.As the score increases, mothers' problem-solving skills increase.
at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
Preparation for Discharge from Neonatal Intensive Care Unit and Home Care Scale
Time Frame: at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
The scale developed for mothers includes 4 sub-dimensions (feeding, general condition perception, hygienic care, care practices). A minimum of 22 and a maximum of 154 points can be obtained from the mother scale. High scores indicate that parents are ready for discharge.
at birth; through birth, an average of 3 months; through discharge, an average of 3 day; through discharge, an average of 3 month
Process Evaluation Form
Time Frame: through discharge, an average of 3 month
9 open-ended questions are asked about the benefits of the program, satisfaction levels with the program, the effects of the program on the feeling of knowledge and competence in baby care, the conveniences and difficulties of the program, and suggestions for the program.This form is a form in which qualitative and quantitative data are collected. Therefore, it has no upper and lower scores.
through discharge, an average of 3 month
Ankara Developmental Screening Inventory
Time Frame: through discharge, an average of 1 month; through discharge, an average of 3 month
It is a screening inventory that provides in-depth and systematic information about the development of babies and children (0 -6 years old).The inventory consists of 4 subdomains: language-cognitive, fine motor, gross motor and social skills-self-care.
through discharge, an average of 1 month; through discharge, an average of 3 month
Baby Monitoring Form
Time Frame: at birth, 1st month, 3rd month
receiving emergency healthcare services after discharge (rate)
at birth, 1st month, 3rd month
Baby Monitoring Form
Time Frame: at birth, 1st month, 3rd month
Growth-development parameters of birth, discharge and home care (weight in kilograms)
at birth, 1st month, 3rd month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2023

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

November 1, 2023

First Submitted That Met QC Criteria

November 16, 2023

First Posted (Estimated)

November 22, 2023

Study Record Updates

Last Update Posted (Estimated)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 16, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Growth

Clinical Trials on Web-Based Monitoring Program

3
Subscribe